Katie Neith

Pages Tagged with "Katie Neith"

City of Hope to present new research at the American Association of Cancer Research (AACR) Annual Meeting 2024, highlighting promising data on prostate, colorectal and pancreatic cancer
Studies focus on molecular profiling, CAR T cell therapies, early detection and artificial intelligence applications in cancer researchCONTACTLetisia Marquez626-476-7593lemarquez@coh.org LOS ANGELES — Researchers with City...
City of Hope-developed chimeric antigen receptor (CAR) T cell therapy shows clinical activity in patients with aggressive brain tumors in a Phase 1 trial
•    Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced complete response•    Nature Medicine paper highlights delivery of CAR T...
City of Hope Research Reveals an Immune Cell That Can Attack Cancer
According to preclinical research published online today in Cell, one of the world’s premier scientific journals, researchers at City of Hope® have discovered that a type of immune cell...
City of Hope research reveals an immune cell that can attack cancer
 Preclinical findings reported in the journal Cell could lead to a new type of immunotherapy CONTACTLetisia Marquez626-476-7593lemarquez@coh.orgLOS ANGELES — According to preclinical research published online...
Study identifies promising treatment for advanced colorectal cancer
An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compared to standard of...
City of Hope part of successful international Phase 3 clinical trial evaluating sotorasib medication combination for patients with metastatic colorectal cancer
The novel therapeutic tested at City of Hope could provide a new option for patients with a treatment-resistant tumor mutation called KRAS G12CCONTACTZen Logsdon626-409-9367zlogsdon@coh.org 
RESEARCH ALERT: City of Hope researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy
Findings reveal potential pathway for addressing such resistance in lung cancer patients CONTACT Letisia Marquez lemarquez@coh.org (626) 476-7593 FINDINGS In a recent study led by Ravi Salgia, M.D., Ph.D...
New minimally invasive prostate cancer treatment helps preserve function
After positive initial results, they led the City of Hope arm of a large, multisite Phase 2b trial of the technology, providing important data (published in Lancet Oncology in...
RESEARCH ALERT: City of Hope scientists identify new therapeutic target for metastatic cancer
CONTACT Letisia Marquez lemarquez@coh.org (626) 476-7593 FINDINGS In a recent study led by Lei Jiang, Ph.D., an assistant professor of molecular and cellular endocrinology, a team of researchers from...
City of Hope researchers to present exciting new treatments at ASCO 2023
City of Hope physicians will present research on promising treatments for blood, prostate and other cancers, as well as studies on genetic testing for hereditary cancers and on reducing heart...